(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(0.29%) $78.34
(0.19%) $2.15
(0.44%) $2 318.80
(1.72%) $27.15
(-0.60%) $959.55
(0.03%) $0.929
(-0.04%) $10.87
(0.01%) $0.797
(0.00%) $91.45
-0.61% $ 9.80
Live Chart Being Loaded With Signals
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions...
Stats | |
---|---|
Tagesvolumen | 5 053.00 |
Durchschnittsvolumen | 2 768.00 |
Marktkapitalisierung | 46.40M |
EPS | $0 ( 2024-03-13 ) |
Nächstes Ertragsdatum | ( $0 ) 2024-07-10 |
Last Dividend | $0.0300 ( 2018-01-05 ) |
Next Dividend | $0 ( N/A ) |
P/E | 70.00 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-27 | Michel Robert J | Buy | 750 | Daxor Common Stock |
2024-03-04 | Feuer Edward | Buy | 1 000 | Daxor Common Stock |
2023-12-06 | Michel Robert J | Buy | 120 | Daxor Common Stock |
2023-12-01 | Michel Robert J | Buy | 180 | Daxor Common Stock |
2023-12-01 | Feldschuh Michael Richard | Buy | 800 | Daxor Common Stock |
INSIDER POWER |
---|
56.67 |
Last 97 transactions |
Buy: 668 992 | Sell: 434 444 |
Daxor Corp Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Daxor Corp Finanzdaten
Annual | 2023 |
Umsatz: | $34.59M |
Bruttogewinn: | $34.41M (99.49 %) |
EPS: | $0.0606 |
FY | 2023 |
Umsatz: | $34.59M |
Bruttogewinn: | $34.41M (99.49 %) |
EPS: | $0.0606 |
FY | 2022 |
Umsatz: | $6.31M |
Bruttogewinn: | $5.22M (82.77 %) |
EPS: | $1.270 |
FY | 2021 |
Umsatz: | $5.82M |
Bruttogewinn: | $0.00 (0.00 %) |
EPS: | $1.170 |
Financial Reports:
No articles found.
Daxor Corp Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.500 | 1997-04-28 |
Last Dividend | $0.0300 | 2018-01-05 |
Next Dividend | $0 | N/A |
Payout Date | 2018-01-12 | |
Next Payout Date | N/A | |
# dividends | 20 | -- |
Total Paid Out | $5.11 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.17 | -- |
Div. Sustainability Score | 2.66 | |
Div.Growth Potential Score | 0.487 | |
Div. Directional Score | 1.571 | -- |
Year | Amount | Yield |
---|
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
KCCA | Ex Dividend Junior | 2023-06-28 | Semi-Annually | 0 | 0.00% | |
SACH | Ex Dividend Knight | 2023-08-04 | Quarterly | 0 | 0.00% | |
AIVI | Ex Dividend Junior | 2023-06-26 | Quarterly | 0 | 0.00% | |
EIM | Ex Dividend King | 2023-09-21 | Monthly | 0 | 0.00% | |
ICAP | Ex Dividend Knight | 2023-08-29 | Monthly | 0 | 0.00% | |
PPI | Ex Dividend Junior | 2023-06-26 | Quarterly | 0 | 0.00% | |
DFAT | Ex Dividend Junior | 2023-09-19 | Quarterly | 0 | 0.00% | |
GLU | Ex Dividend Knight | 2023-10-16 | Monthly | 0 | 0.00% | |
NSPI | Ex Dividend Junior | 2023-09-20 | Monthly | 0 | 0.00% | |
COHN | Ex Dividend Junior | 2023-08-17 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0121 | 1.500 | 9.76 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0121 | 1.200 | 9.60 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0131 | 1.500 | -0.966 | -1.449 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0.251 | 0.800 | -3.74 | -3.00 | [1 - 3] |
quickRatioTTM | 0.138 | 0.800 | -3.90 | -3.12 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0.0217 | -1.500 | 9.64 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -6.56 | 1.000 | -3.54 | -3.54 | [3 - 30] |
operatingCashFlowPerShareTTM | -1.712 | 2.00 | -0.571 | -1.141 | [0 - 30] |
freeCashFlowPerShareTTM | -1.712 | 2.00 | -0.856 | -1.712 | [0 - 20] |
debtEquityRatioTTM | 0.0222 | -1.500 | 9.91 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.987 | 1.000 | 10.00 | 10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.00928 | 1.000 | -2.19 | -2.19 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -10.89 | 1.000 | -10.00 | -10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.994 | 0.800 | 6.70 | 5.36 | [0.5 - 2] |
Total Score | 2.66 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 111.89 | 1.000 | 10.00 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0131 | 2.50 | -0.621 | -1.449 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -1.712 | 2.00 | -0.571 | -1.712 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -1.712 | 2.00 | -0.571 | -1.141 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 1.286 | 1.500 | 4.76 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -0.237 | 1.000 | -8.43 | 0 | [0.1 - 0.5] |
Total Score | 0.487 |
Daxor Corp
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.